Delivery Order SPE2DB24D2018-SPE2DB25FWRJ6
Award Date
10/16/24
Potential Completion Date
10/17/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,752.95 firm-fixed-price delivery order is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a performance period ending on June 13, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,176.72 Firm Fixed Price delivery order is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of May 9, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a $15,022.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of January 30, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a $2,504.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a diabetes treatment medication, with a performance period ending on June 16, 2025. This award is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 firm fixed-price delivery order is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,909.55 firm fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,836.55 firm fixed-price contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes and other conditions. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $19,887.88 and an ultimate completion date of May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $14,813.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The contract is a firm fixed-price arrangement with an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...